2seventy bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-217.57	-254.15	-292.21	-120.11	-320.59	-199.75
Depreciation & Amortization	10.29	11.53	16.35	13.19	12.59	13.35
Share-Based Compensation	32.16	41.04	54.63	61	62.05	40.8
Other Operating Activities	8.27	-26.56	14.38	-21.86	38	-0.61
Operating Cash Flow	-166.86	-228.14	-206.86	-67.79	-207.96	-146.22
Capital Expenditures	-13.87	-30.81	-11.58	-22.26	-59.77	-50.83
Change in Investments	57.73	34.56	1.99	0	0	0
Other Investing Activities	-	-	-8	-	-	-
Investing Cash Flow	43.86	3.75	-17.59	-22.26	-59.77	-50.83
Share Issuance / Repurchase	127.39	166.23	0	0	0	0
Debt Issued / Paid	0	0	0	0	0	2.08
Other Financing Activities	-	-	354.89	90.05	267.72	194.96
Financing Cash Flow	127.39	166.23	354.89	90.05	267.72	197.04
Net Cash Flow	4.39	-58.16	130.45	0	0	0
Free Cash Flow	-180.72	-258.95	-218.43	-90.05	-267.72	-197.04
Free Cash Flow Margin	-180.03%	-283.02%	-400.63%	-36.29%	-604.39%	-361.02%
Free Cash Flow Per Share	-3.67	-7.27	-9.29	-3.85	-11.46	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).